Scarica l'app Stockscreener
4.94
0.82%
0.04
Dopo l'orario di chiusura:
4.94
Vanda Pharmaceuticals Inc Azioni (VNDA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
4.84%
47.46
|
45.27 | 38.81 | 46.06 | 62.50 |
Operating Expenses
|
8.27%
56.70
|
52.37 | 44.81 | 48.92 | 60.49 |
| Benefits Costs and Expenses |
11.07%
52.13
|
46.93 | 38.94 | 43.46 | 56.97 |
| Costs And Expenses |
8.27%
56.70
|
52.37 | 44.81 | 48.92 | 60.49 |
| Operating Income/Loss |
30.18%
-9.235
|
-7.094 | -5.995 | -2.867 | 2.004 |
| Income/Loss From Continuing Operations Before Tax |
180.79%
-4.664
|
-1.661 | -0.12 | 2.592 | 5.528 |
| Income Tax Expense/Benefit, Deferred |
96.71%
-0.246
|
-7.484 | 2.729 | 1.455 | 2.014 |
| Income Tax Expense/Benefit |
170.09%
-0.518
|
0.739 | -0.257 | 1.072 | 2.276 |
| Income/Loss From Continuing Operations After Tax |
72.75%
-4.146
|
-2.40 | 0.137 | 1.52 | 3.252 |
|
Net Income/Loss
|
72.75%
-4.146
|
-2.40 | 0.137 | 1.52 | 3.252 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
113.14K%
57.76
|
0.051 | 57.52 | 57.45 | 57.01 |
| Diluted Average Shares |
126.33K%
57.76
|
0.0457 | 57.60 | 57.54 | 57.40 |
| Basic Earnings Per Share |
40.00%
-0.07
|
-0.05 | - | 0.03 | 0.06 |
| Diluted Earnings Per Share |
40.00%
-0.07
|
-0.05 | - | 0.03 | 0.06 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):